AMGN – Biologics Manufacturing Facility – US - Project Profile
"AMGN – Biologics Manufacturing Facility – US - Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts.
The "AMGN – Biologics Manufacturing Facility – US - Project Profile" is part of Timetric's database of 82,000+ construction projects. Our database includes a 10+ year archive of completed projects, full coverage of all global projects with a value greater than $25 million and key contact details for project managers, owners, consultants, contractors and bidders.
Amgen, Inc (AMGN) is planning to build a biologics manufacturing facility in the US.
The project involves the construction of a biologics manufacturing facility. It includes the construction of a production plant, a laboratory, a testing unit, a storage facility, an administrative facility and a parking facility, and the installation of machinery, safety and security system.
AMGN expects to finalize the exact location of the facility in the second quarter of 2018.
As of February 2018, feasibility study activities are underway.
The project involves the construction of a biologics manufacturing facility in the US.
The US$300 million project includes the following:
1. Construction of a production plant
2. Construction of a laboratory
3. Construction of a testing unit
4. Construction of a storage facility
5. Construction of an administrative facility
6. Construction of a parking facility
7. Installation of machinery
8. Installation of safety security systems
Reasons To Buy